Treatment of Latent TB with Positive PPD and Negative Chest X-Ray
Yes, treat for latent tuberculosis infection with isoniazid for 9 months after excluding active disease. 1, 2
Confirming Latent TB vs Active Disease
A positive PPD with a negative chest radiograph and absence of symptoms effectively confirms latent TB infection rather than active disease. 3 The key steps are:
- Obtain chest radiograph to exclude active pulmonary tuberculosis, looking specifically for infiltrates, cavitation, or Ghon complex 1
- Assess for symptoms of active TB including fever, night sweats, weight loss, cough, or hemoptysis 1
- Consider sputum examination only if symptoms are present or chest radiograph is abnormal 1
A normal chest radiograph and negative sputum culture effectively rule out active pulmonary tuberculosis. 3
Treatment Regimen for Latent TB
The preferred regimen is isoniazid 300 mg daily for 9 months. 1, 2 This is the standard recommendation from the CDC and FDA for latent TB infection. 3, 2
Alternative regimens include:
- Rifampin for 4 months as an acceptable alternative 1
- Rifampin plus isoniazid for 3 months (though not included in older CDC recommendations, this has equivalent efficacy) 4
Risk Stratification Determines Treatment Threshold
The PPD positivity threshold varies by risk category: 1, 2
≥5 mm induration is positive for:
≥10 mm induration is positive for:
≥15 mm induration is positive for:
Critical Monitoring During Treatment
Baseline liver function tests are mandatory before initiating isoniazid. 1, 3 Follow-up includes:
- Monitor liver enzymes every 2-4 weeks during treatment 1
- Assess clinically for hepatotoxicity symptoms including nausea, vomiting, jaundice, or abdominal pain 1
- Monthly clinical monitoring is essential to assess adherence and adverse effects 3
Special Considerations and Common Pitfalls
Do not withhold treatment based solely on BCG vaccination history. 1 The PPD should be interpreted the same way regardless of prior BCG vaccination in persons with risk factors. 1
Anergy testing is controversial and generally not recommended. 1 Even if a patient is anergic, the risk of TB in the presence of a negative PPD is low (0-10% in immunocompromised patients). 1
For patients from areas with >10% drug resistance, consider two-drug therapy even for latent infection. 1
HIV-infected patients require special attention:
- All HIV-positive patients with ≥5 mm induration should receive treatment 3, 2
- Treatment duration should be at least 12 months in HIV-infected persons 3, 2
- CD4 count influences tuberculin sensitivity; patients with advanced immunosuppression may have false-negative results 3, 5
Age considerations for hepatotoxicity risk:
- The risk of isoniazid hepatitis increases with age, particularly over 35 years 2
- However, treatment is still recommended when additional risk factors are present (HIV, recent conversion, close contact, abnormal chest radiograph, immunosuppression) 2
- Weigh hepatitis risk against TB progression risk on an individual basis for those over 35 without additional risk factors 2
When Treatment is Mandatory
Treatment is particularly critical for: 2